Drug Price Negotiation by the Inflation Reduction Act

CEimpact Podcast

The cost of medications is often attributed to a burden on healthcare - despite hospitalizations costing four times as much. Join host, Geoff Wall, as he discusses the new Inflation Reduction Act which allows the government to negotiate medication prices.
The GameChanger
The US Federal Government can now negotiate with drug companies for the cost of medications. Similar to other countries, this bulk buying power can help lower medication prices for patients.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
HHS Selects the First Drugs for Medicare Drug Price Negotiation
https://www.hhs.gov/about/news/2023/08/29/hhs-selects-the-first-drugs-for-medicare-drug-price-negotiation.html
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. List the 10 medications first targeted by the new legislation for negotiation
2. Describe the common arguments against this provision of the Inflation Reduction Act
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-321-H03-P
Initial release date: 10/2/2023
Expiration date: 10/2/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Chapters

1. Drug Price Negotiation by the Inflation Reduction Act (00:00:00)

2. Negotiating Medicare Part D Drug Prices (00:00:08)

3. Rules and Negotiation for Drug Pricing (00:08:48)

4. The Benefits of Negotiating Drug Costs (00:23:03)